Daiichi Sankyo Company (4568-TO)

The Economic Times  Nov 2  Comment 
Ajanta Pharma's Amlodipine + Olmesartan Medoxomil tablets are a generic version of Daiichi Sankyo Inc's Azor tablets​
newratings.com  Oct 31  Comment 
TOKYO (dpa-AFX) - Daiichi Sankyo Company Limited(DSKYF.PK)reported that its profit attributable to owners of the Company First Six Months of fiscal 2016 decreased by ¥21.7 billion, or 30.7% year on year, to ¥49.0 billion. The profit attributable...
The Hindu Business Line  Oct 27  Comment 
Sun Pharmaceutical Industries has launched generic versions of Daiichi Sankyo medicines, used in the treatment of high blood pressure, in the US market.In a BSE filing, Sun Pharmaceutical Industries ...
GenEng News  Oct 4  Comment 
Daiichi Sankyo and AgonOx will partner to develop an immuno-oncology target, the companies said today, through a collaboration whose target and value were both not disclosed. Daiichi Sankyo and AgonOx agreed to team up on preclinical...
newratings.com  Jul 14  Comment 
THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) and Daiichi Sankyo Company, Limited (DSKYF.PK) announced the execution of an exclusive agreement to commercialize nine biosimilars in Japan. The deal includes several biosimilars in late-stage development,...
GenEng News  Jun 1  Comment 
Nektar Therapeutics said today it has granted Daiichi Sankyo Europe exclusive rights to market the registration-bound cancer drug Onzeald™ (etirinotecan pegol) in Europe, Switzerland, and Turkey. The deal could generate up to $80...
Financial Times  May 10  Comment 
Daiichi Sankyo pays Welsh start-up £12.5m for regenerative medicine to fix damaged heart tissue
FiercePharma  Feb 12  Comment 
A parade of politicians, physicians and pundits have criticized a Super Bowl commercial intended to stimulate awareness of opioid-induced constipation, linking the campaign to the opioid prescription drug addiction problem in the U.S. and forcing...

You may also be interested in articles related to Daiichi Sankyo Company (4568-TO):
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki